|

At your
discretion, Bio-Reference will (1) bill your office directly for
services rendered to your patients (in those States that allow doctor
billing), (2) bill your patient directly or (3) bill any of the
third party insurance carriers that Bio-Reference is able to bill
directly, if your patient is an enrollee of one of these third party
carriers and, if you provide us with the necessary information.
Our
computerized billing department submits electronic claims to our
insurance carriers plus individual statements to patients and clients.
Bio-Reference is currently a provider for the insurance companies
listed below:
1199 National Benefit Fund
Allied Welfare Fund
Americaid
American Medical Life Insurance, Co.
American Preferred Provider Plan
Blue Shield of New Jersey, New York,
Connecticut, Pennsylvania, Florida, Texas
Careplus Health Plan
Champus
Complete Care
Federal Black Lung Program
G.H.I.
Health Care Payers Coalition of NJ
(effective 5-27-98)
HealthSource (P.P.O.)
HEALTHNET & BLUECHOICE (HMO and PPO of N.Y.B.S.)
J.J. Newman & Co.
Local 812, Softdrink & Brewery Workers
MagnaCare
Managed Health, Inc.
Medicaid of Connecticut, DC, Florida, Illinois, Indiana, Kentucky,
Louisiana, Maryland, Minnesota, New Jersey, Pennsylvania, Texas
and Virginia
Medicare
Multi Plan, Inc.
The National Care Network
National Health Plan
Ohio Bureau of Worker's Compensation
P.H.C.S. (Private Healthcare Systems)
POMCO
Select Pro
S.O.L.O. (Solidarity of Labor Organizations International Union)
S.W.S.C.H.P. (State-Wide Schools Cooperative Health Plan) (NY)
United Healthcare (Empire, General Motors, NY Power Auth., L.I.R.,
Health Research and Con Ed)
U.S. Healthcare (as of 11-1-96, Fertility Testing Only)
Wellness Plus
Westchester Prepaid Services, Inc./Health Source
Direct Billing To The Patient
Bio-Reference
will bill your patients directly for our services. The patients
full name, street address including apartment number, city, state
and zip code must be clearly printed in the space provided on the
requisition (including Social Security Number). A complete address
at the time the test is ordered is essential. Each requisition will
result in a separate bill to the patient. Payment of patient bills
is due upon receipt and, if not paid, will be followed by subsequent
reminders and normal collection activity.
Direct Billing To Medicare
As a result of legislation signed into law on July 18, 1984, Bio-Reference
is required to bill Medicare directly for all laboratory testing
(with the exception of anatomic pathology) that is referred to us
by any physician. Except in those cases, Medicare will deny payment
to anyone other than the laboratory that performed the test. Please
be sure to identify any of your patients who are eligible for Medicare
coverage by so noting on the test requisition.
In order to bill Medicare, we require the following information.
If you have any questions, please feel free to call us.
1. Patient Name
2. Patient Address (Including Zip code)
3. Patient Sex
4. Patient Signature
5. Patient Medicare (HIC) # 9 numerics plus 1 or 2 alpha/numeric
suffix). If United Healthcare (1-3 alpha plus 6-9 numerics)
6. Medicare currently requires that you provide an appropriate diagnosis
code for specific laboratory tests.
7. Referring Physician and UPIN (1 alpha 5 numerics)
Direct Billing To Third Party
For patients who are subscribers or recipients of benefits from
one of the agencies listed on page 47, Bio-Reference will bill the
patient directly for services not covered by their contract or program,
for any amount that has been applied towards a deductible, and for
any balance due after payment up to the terms of their specific
contract. Payment is due upon receipt, and if not paid, will be
followed by subsequent reminders and normal collection activities.
Please be certain to include all necessary information in the space
provided on the requisition at the time the test is ordered. Complete
information avoids the need to interrupt and impose upon your staff
or patients with requests for information not initially provided.
AGENCY AND REQUIRED BILLING INFORMATION
New Jersey Medicaid
1. Patient Name
2. Patient Address
3. Patient Date of Birth
4. Patient Sex
5. Patient Signature
6. Medicaid ID # (10 numerics plus 2 numerics/person # suffix)
7. Diagnosis Code
8. Referring Physician and provider number (7 numerics)
9. Physician Signature
Connecticut Medicaid
1. Patient Name
2. Patient Address
3. Date of Birth
4. Patient Sex
5. Patient Signature
6. Medicaid ID # (9 numerics)
7. Diagnosis Code
8 Referring Physician and provider number
9. Physician Signature
New Jersey, New York, Connecticut, Pennsylvania, Florida and
Texas Blue Shield
1. Patient Name
2. Patient Address
3. Patient Date of Birth
4. Patient Sex
5. Patient Signature
6. Subscriber Name, Address, Date of Birth
7. Patient's Relationship to Subscriber
8. Blue Shield ID # plus group number
9. Diagnosis Code
10.Referring Physician and Signature
G.H.I.
1. Patient Name
2. Patient Address
3. Date of Birth
4. Patient Sex
5. Patient Signature
6. Subscriber Name, Address, Date of Birth
7. Patient's Relation to Subscriber
8. G.H.I. ID # - Social Security Number plus group number (9 digits)
9. Diagnosis Code
10.Referring Physician and Signature
1199 National Benefit Fund
1. Patient Name
2. Patient Address
3. Date of Birth
4. Patient Sex
5. Patient Signature
6. 1199 National I.D. # (9 numerics)
7. Subscriber Name, Address, Date of Birth
8. Patient Relationship to Subscriber
9. Diagnosis Code
10. Referring Physician and Signature
All Other Insurances
1. Patient Name
2. Patient Address
3. Patient Date of Birth
4. Patient Sex
5. Patient Signature
6. Subscriber Name, Address, Date of Birth
7. Patient's Relationship to Subscriber
8. ID # plus group number
9. Diagnosis Code
10.Referring Physician and Signature
NOTICE
Bio-Reference Laboratories, Inc. has a fiduciary responsibility
to remind physicians that when they order tests in which Medicare/Medicaid
reimbursement will be sought, physicians should only order tests
that are medically necessary. This means that only tests
which are required for the diagnosis or treatment of a patient can
be ordered for tests reimbursed by Medicare/Medicaid. This government
policy eliminates all testing for screening purposes only.
Medicare Patients Must Pay For Tests Ordered Outside Utilization
Guidelines
Utilization
parameters have been developed based on comments received from Medicares
Carrier Advisory Committees and Professional Consultants for
laboratory tests. The parameters represent the normal utilization
of the test. Medicare recognizes that some clinical conditions may
require testing at a frequency which exceeds these guidelines. Likewise,
providers may find testing at lower frequencies to be appropriate.
Claims submitted for services which exceed these guidelines require
additional documentation before payment is made.
Glycated Hemoglobin (83036)
1 every 3 months, except 1 per month during pregnancy
Lipid Panel (80061) 1 every 4 months
Ferritin (82728) 1 every 2 months
Pap Smear (88156) 1 every 3 years
When
ordering any of the tests above outside of their corresponding utilization
guidelines and without additional documentation, please have the
patient sign the Patient Waiver Section of the requisition form,
so they may be billed directly for the test.
Procedures Of Questionable Current Usefulness
The
following tests are considered "Procedures of Questionable
Current Usefulness" by Medicare and require documentation which
satisfactorily establishes the procedure's medical necessity (letter
of medical necessity). The reference is Medicare Medical Policy
Bulletin No. G-33. If a letter of medical necessity can not be provided,
please have the patient sign the Patient Waiver section of the requisition
form, so they may be billed directly for the test.
| LAB
TEST CODE |
DESCRIPTION |
CPT
CODE |
| 1232 |
17-HYDROXYPREGNENOLONE |
84143 |
| 1613
|
3-ALPHA
ANDROSTANEDICOL-G |
82154 |
| 2128 |
ADRENAL
STEROIDS |
84999 |
| 0608 |
ANTI-GLIADIN
AB., SERUM |
84999
x 2 |
| 0451
|
APOLIPOPROTEIN
A1 |
82172 |
| 1639
|
LIPOPROTEIN
a (Lp-a) |
82172 |
| 0457
|
APOLIPOPROTEIN
B |
82172 |
| 0895 |
APOLIPOPROTEIN
A-1, B |
82172
x 2 |
| 0427 |
ARSENIC
24 HR. URINE |
82175 |
| 0845 |
ARSENIC
BLOOD |
82175 |
| 2155 |
ARYLSULFATASE
A, 24 hr. URINE |
84999 |
| 1447 |
ATRIAL
NATRIURETIC FACTOR (ANF) |
84999 |
| 1310 |
BETA
ENDORPHIN |
84999 |
| 1596 |
CORTICOTROPIN
RELEASING HORMONE |
84999 |
| 2426
|
ENDOTHELIN-I |
84999 |
| 1428
|
FELBAMATE |
80299 |
| 1611
|
FIBRONECTIN
AGGREGATES, IGA |
84999,
82784 |
| 0111 |
HEXOSAMINIDASE
A (TAY SACHS) |
84999 |
| 1866 |
HYDROXYCORTISOL
18 |
84999 |
| 1316
|
IGF-BP3 |
84999 |
| 2474 |
INSULIN-LIKE
GROWTH FACTOR II |
84999 |
| 1104 |
INTERLEUKIN-1b
(IL-1b) |
84999 |
| 1026 |
INTERLEUKIN-6
(IL-6) |
84999 |
| 0398 |
LEAD,
BLOOD |
83655 |
| 0808 |
LEAD,
URINE (24 HR.) |
83655 |
| 0631 |
MELANO.
STIM. HORMONE (GAMMA) |
84999 |
| 0635 |
MELANO.
STIM. HORMONE (BETA) |
84999 |
| 0632 |
MELANO.
STIM. HORMONE (ALPHA) |
84999 |
| 1304 |
MESANTOIN,
SERUM |
84999 |
| 1270 |
METHYLDOPA
(ALDOMET) |
80299 |
| 0909 |
MHPG,
24HR. URINE |
84999 |
| 2192
|
MYELOPEROXIDASE
Ab. |
84999 |
| 2154 |
NEURONTIN
(GABAPENTIN), SERUM |
80299 |
| 2165 |
NIACIN
LEVEL |
84999 |
| 1368 |
NITROGLYCERINE |
80299 |
| 1594 |
PEPSINOGEN,
SERUM |
84999 |
| 0963 |
PROPOXYPHENE,
URINE, QUAL. |
80299 |
| 0232 |
SELENIUM,
SERUM |
84255 |
| 1767 |
SILICATE
Abs. (IgG/IgM) |
84999
x 2 |
| 2078 |
SILVER
LEVEL, 24 hr. |
84999 |
| 1716
|
SULFATIDE
ANTIBODY, IGM |
84999 |
| 2105 |
TH1-TH2
EVALUATION |
84999
x 4 |
| 0415 |
THIOTHIXENE,
PLASMA |
80299 |
| 2127 |
THYROTROPIN
RELEASING HORMONE |
84999 |
| 1266 |
TOCAINIDE
LEVEL |
80299 |
| 2163 |
TROPONIN-I |
84512 |
| 2098 |
TRYPSINOGEN,
SERUM |
84999 |
| 2148
|
TRYPTASE,
SERUM |
84999 |
Experimental Investigational Tests
These
tests are considered experimental/investigational by Medicare. Services
performed in connection with research or experimental studies are
excluded from payment and therefore require that the patients
sign the Patient Waiver Section of the requisition form. The
following CPT codes were acquired from the Medicare Reference Manual,
Chapter 6 : 82523, 85337, 86343, 86602, 86619, 86682, 86717, 86723,
86732, 86741, 86750, 86753, 86768, 86771, 86774, 88358, 88371, and
88372.
| LAB
TEST CODE |
DESCRIPTION |
CPT
CODE |
| 1143
|
AMOEBA
ANTIBODY PANEL (ID/IHA) |
86753 |
| 1713 |
COLLAGEN
STUDIES |
82523 |
| 5585 |
DNA
PLOIDY (IMAGE ANALYSIS) |
88358 |
| 1752 |
LISTERIA
AB IGG |
86723 |
| 2158
|
N-TELLO
PEPTIDE/COLLAGEN |
82523 |
| 1636 |
SALMONELLA
ANTIBODIES (G/A/M) |
80099 |
| 2145 |
SEND-OUT
(DNA PLOIDY/IMAGE) |
88182 |
| 0974 |
TETANUS
ANTITOXIN ASSAY, SERUM |
86774 |
| 0460 |
TYPHUS
FEVER ANTIBODY |
80099 |
Non-Covered Tests
These
tests are considered "non-covered services" and will not
be paid for by Medicare. These tests DO NOT require that
the patients sign the Patient Waiver Section of the requisition
form: 81025, 81050, 83518, 86710 and 86735.
| LAB
TEST CODE |
DESCRIPTION |
NON-COVERED
CPT |
| 0689
|
CHLAMYDIA
AG. IMMUNO.(GENITAL) |
87320 |
| 0726
|
CHLAMYDIA
AG. IMMUNO.(URINE) |
87320 |
| 0818 |
INFLUENZA
Ab. TYPES A/B |
80099 |
| 1855 |
LYME
AG URINE |
87449 |
| 1151 |
MUMPS
VIRUS TITER (IgM) |
86735 |
| 0316 |
MUMPS
VIRUS AB. (IgG) |
86735 |
| 0946 |
PARA-INFLUENZA
Ab. |
80099 |
| 2006 |
PARK
AVE PREGNANCY URINE |
81025 |
| 0133 |
PREGNANCY
URINE |
81025 |
| 0643 |
URINE
VOLUME (TIMED PERIOD) |
81050 |
Medicare
has instituted certain changes with regard to the processing of
laboratory claims for Medicare patients that affect both the laboratory
and the physician. Most of you are aware that if a diagnosis
code does not accompany a Medicare claim, the claim will be rejected.
However,
on June 3, 1996, Medicare instituted a new policy; whereby payment
for the following tests will only be made if an Appropriate
Diagnosis Code accompanies the claim.
Effective
as of the dates of service listed below, the following laboratory
tests require patient diagnosis information in order to be reimbursed:
| Test |
CPT
Code |
Date
of Service |
| Alpha-fetoprotein
(AFP |
82105 |
January
1, 1997 |
| Bacterial
Urine Culture |
87086,87088 |
June
29, 1996 |
| Blood
Counts |
85007
- 85031 |
June
29, 1996 |
| Ca125 |
86316 |
January
1, 1997 |
| Ca27.29 |
86316 |
January
1, 1997 |
| Carcinoembryonic
Antigen |
82378 |
June
3, 1996 |
| Digoxin |
80162 |
June
29, 1996 |
| Ferritin |
82728 |
June
3, 1996 |
| Glucose |
82947,
82948, 82962 |
June
3, 1996 |
| Glycated
Protein |
82985 |
June
3, 1996 |
| Glycated
Hemoglobin |
83036 |
June
3, 1996 |
| Hepatitis |
86287,
86289, 86290, 86291, 86302 |
April
28, 1997 |
| Lipid
Panel |
80061,
82465, 83718, 84478 |
June
3, 1996 |
| Magnesium |
83735 |
June
3, 1996 |
| Pap
Smear |
88156 |
May
15, 1995 |
| Phosphate,
acid prostatic |
84066 |
June
29, 1996 |
| Prostate
Specific Ag (PSA) |
84153 |
June
3, 1996 |
| Prothrombin
Time |
85610 |
June
29, 1996 |
| Syphilis
Test, Qualitative |
86592 |
June
29, 1996 |
| Thyroid
Function Studies |
80091,
80092, 84436, 84443, 84479 |
|
Treponema
Pallidum
- (MHA-TP
RPR Confirm Test)
|
86781 |
Oct.
21, 1996 |
The
Medicare Special Notice, dated April 23, 1996, states specifically
that:
A
provider, by virtue of furnishing a laboratory service to a Medicare
beneficiary, is responsible for making a judgment as to whether
the service is medically necessary and for informing the beneficiary
in writing prior to furnishing the service, of the likelihood
of Medicare denial of payment on the basis that the service is
not reasonable and necessary. If the provider fails to verify
the medical necessity of ordered tests, and the tests are subsequently
determined not to be medically necessary, the provider may be
held liable for payment unless the beneficiary received advanced
notice of the likelihood of the denial.
Therefore,
if the physician does not provide an Appropriate Diagnosis Code
for the aforementioned tests listed above, then Medicare will
not pay for the test. In order to make the patient responsible
for the payment of a test, their written consent must be obtained
prior to performing the test. The recommendation of Medicare is
that the laboratory should not run the specimen unless it has
an appropriate diagnosis code or a patient waiver accepting responsibility
for payment of the test. If the physician does not obtain the
waiver, then the laboratory, according to Medicare, should contact
the patient directly prior to performing the test to obtain a
waiver.
Under
the U.S. fiscal year 1988 Budget Reconciliation package Congress
has approved that beginning January 1, 1998, physicians must provide
diagnostic information at the time a laboratory test is ordered.
Therefore, it is Bio-References policy to require diagnosis
codes on all requisition forms.
Disease
Specific Profiles
| CODE |
PROFILE |
| 3422-3 |
Hepatic
Function Panel A (with Bilirubin, total and direct) (80058)
Albumin, serum (82040)
Bilirubin, total and direct (82251)
Phosphatase, alkaline (84075)
Transferase, aspartate amino (AST( (SGOT) (84450)
Transferase, alanine amino (ALT) (SGPT) (84460)
|
| 2555-1 |
Basic
Metabolic Panel (80049)
Carbon dioxide (bicarbonate) (82374)
Chloride; blood (82435)
Creatinine; blood (82565)
Glucose; quantitative (82947)
Potassium; serum (84132)
Sodium; serum (84295)
Urea nitrogen; quantitative (84520)
|
| 0002-6 |
Electrolytes
Panel (80051)
Carbon dioxide (bicarbonate) (82374)
Chloride; blood (82435)
Potassium; serum (84132)
Sodium; serum (84295)
|
| 3427-2 |
Comprehensive
Metabolic Panel (80054)
Albumin; serum (82040)
Bilirubin; total (82250)
Calcium; total (82310)
Carbon dioxide (82374)
Chloride; blood (82435)
Creatinine; blood (82565)
Glucose; quantitative (82947)
Phosphatase; alkaline (84075)
Potassium; serum (84132)
Protein; total, except refractometry (84155)
Sodium; serum (84295)
Transferase; aspartate amino (AST) (SGOT) (84450)
|
|